This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (113)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology, Other  • Alert me on articles by topic

Implications for Neurology

Matthew Menken, MD; Theodore L. Munsat, MD; James F. Toole, MD

Arch Neurol. 2000;57:418-420.

Because of the epidemiological transition, the global burden of illness has changed. Several factors have contributed to this change, including improvements in maternal and child health, increasing age of populations, and newly recognized disorders of the nervous system. It is now evident that neurologic disorders have emerged as priority health problems worldwide. This is reflected in the Global Burden of Disease Study, jointly published by the World Health Organization and other groups. The proportionate share of the total global burden of disease resulting from neuropsychiatric disorders is projected to rise to 14.7% by 2020. Although neurologic and psychiatric disorders comprise only 1.4% of all deaths, they account for a remarkable 28% of all years of life lived with a disability. This study provides compelling evidence that one cannot assess the neurologic health status of a population by examining mortality statistics alone. Health ministries worldwide must prioritize neurologic disorders, and neurologists must be prepared to provide care for increased numbers of people individually and in population groups.

From the World Federation of Neurology, Research Group on Medical Education, London, England.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Patent Foramen Ovale and Migraine: A Cross-Sectional Study From the Northern Manhattan Study (NOMAS)
Rundek et al.
Circulation 2008;118:1419-1424.
ABSTRACT | FULL TEXT  

Validity of the ID-Migraine screener in the workplace
Siva et al.
Neurology 2008;70:1337-1345.
ABSTRACT | FULL TEXT  

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
Ho et al.
Neurology 2008;70:1304-1312.
ABSTRACT | FULL TEXT  

Mapping Africa's Way Into Prominence in the Field of Neurology
Owolabi et al.
Arch Neurol 2007;64:1696-1700.
ABSTRACT | FULL TEXT  

Readmission and Death After Hospitalization for Acute Ischemic Stroke: 5-Year Follow-Up in the Medicare Population
Bravata et al.
Stroke 2007;38:1899-1904.
ABSTRACT | FULL TEXT  

Obesity, migraine, and chronic migraine: Possible mechanisms of interaction
Bigal et al.
Neurology 2007;68:1851-1861.
ABSTRACT | FULL TEXT  

Introduction: Treatment of Neurological Disorders
Ryan and Slevin
Journal of Pharmacy Practice 2007;20:115-116.
 

A Practical Approach to Headache Treatment
Tucker
Journal of Pharmacy Practice 2007;20:123-136.
ABSTRACT  

The burden of inpatient neurologic disease in two Ethiopian hospitals
Bower et al.
Neurology 2007;68:338-342.
ABSTRACT | FULL TEXT  

Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons
Akerman et al.
J. Pharmacol. Exp. Ther. 2007;320:64-71.
ABSTRACT | FULL TEXT  

Is the Canadian health care system better for neurologic care?
Feasby
Neurology 2006;67:1744-1747.
FULL TEXT  

Recent advances in the diagnosis and management of migraine
Goadsby
BMJ 2006;332:25-29.
FULL TEXT  

Advances in the understanding of headache
Goadsby
Br Med Bull 2005;73-74:83-92.
ABSTRACT | FULL TEXT  

Occipital activation in glyceryl trinitrate induced migraine with visual aura
Afridi et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1158-1160.
ABSTRACT | FULL TEXT  

A Positron Emission Tomographic Study in Spontaneous Migraine
Afridi et al.
Arch Neurol 2005;62:1270-1275.
ABSTRACT | FULL TEXT  

Severe malaria: still counting the costs
Birbeck and Taylor
J. Neurol. Neurosurg. Psychiatry 2005;76:467-468.
FULL TEXT  

Neurologic services in the nations of Africa
Bower and Zenebe
Neurology 2005;64:412-415.
ABSTRACT | FULL TEXT  

Underfunding of Stroke Research: A Europe-Wide Problem
Pendlebury et al.
Stroke 2004;35:2368-2371.
ABSTRACT | FULL TEXT  

Calcitonin Gene-Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
Olesen et al.
NEJM 2004;350:1104-1110.
ABSTRACT | FULL TEXT  

A self-administered screener for migraine in primary care: The ID MigraineTM validation study
Lipton et al.
Neurology 2003;61:375-382.
ABSTRACT | FULL TEXT  

Nervous System Disorders: A Global Epidemic
Bergen and Silberberg
Arch Neurol 2002;59:1194-1196.
ABSTRACT | FULL TEXT  

Treating neurodegenerative diseases
Findley and Baker
BMJ 2002;324:1466-1467.
FULL TEXT  

Demystifying neurology
Menken
BMJ 2002;324:1469-1470.
FULL TEXT  

The neurology clerkship core curriculum
Gelb et al.
Neurology 2002;58:849-852.
ABSTRACT | FULL TEXT  

Migraine -- Current Understanding and Treatment
Goadsby et al.
NEJM 2002;346:257-270.
FULL TEXT